Zobrazeno 1 - 10
of 239
pro vyhledávání: '"H C, Schouten"'
Publikováno v:
Leerboek oncologie ISBN: 9789036824484
Leerboek oncologie
Leerboek oncologie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7ef284c3cb401b1d91f3e09dcd90c57
https://doi.org/10.1007/978-90-368-2449-1_14
https://doi.org/10.1007/978-90-368-2449-1_14
Publikováno v:
Tissue antigens. 86(1)
The full length sequence of HLA-A*02:455 differs from HLA-A*02:01:01:01 by one amino acid substitution: A245E.
Autor:
H C, Schouten
Publikováno v:
Annals of Oncology. 17:x85-x89
Autor:
Marc A. Boogaerts, Ronald Brand, Volker Runde, Jürgen Finke, Jan J. Cornelissen, Enric Carreras, Anja van Biezen, Eliane Gluckman, Andrea Bacigalupo, Antonio Pagliuca, Tapani Ruutu, Dietger Niederwieser, Philippe Guardiola, H. C. Schouten, Theo de Witte, Franco Locatelli
Publikováno v:
Blood, 99, 12, pp. 4370-8
Blood, 99, 4370-8
Blood, 99(2), 4370-4378. American Society of Hematology
Blood, 99, 4370-8
Blood, 99(2), 4370-4378. American Society of Hematology
Item does not contain fulltext In this multicenter retrospective study, the outcomes of 234 patients with myelodysplastic syndrome (MDS) who underwent transplantation between 1995 and 1999 from HLA-identical siblings were analyzed according to the he
Publikováno v:
Tissue antigens. 85(1)
HLA-C*03:219 differs from HLA-C*03:04:01:01 by a non-synonymous substitution in the α3 domain (T216I).
Autor:
M W M, van der Poel, W J, Mulder, G J, Ossenkoppele, E, Maartense, P, Wijermans, M, Hoogendoorn, H C, Schouten
Publikováno v:
The Netherlands journal of medicine. 72(3)
Elderly patients with non-Hodgkin's lymphoma (NHL) are often not treated with standard immunochemotherapy and this might have a negative impact on their survival. Little is known about the determinants that play a role in treatment decision-making of
Publikováno v:
European Journal of Haematology. 52:233-235
Up to 30% of patients with idiopathic thrombocytopenic purpura (ITP) are refractory to standard therapy with corticosteroids and splenectomy. The treatment of refractory ITP is barely effective, but promising results of interferon therapy were report
Autor:
D. J. Richel, Wim E. Fibbe, M. van Marwijk Kooy, A. W. Dekker, Alexandra J. Croockewit, H. C. Schouten, Edo Vellenga, J. J. Cornellissen, Pieter Sonneveld, Bob Löwenberg, H. M. Lokhorst, P. W. Wijermans, S. Wittebol, Christine M. Segeren, M. H. J. Van Oers, Gregor Verhoef, Douwe H. Biesma, B. van der Holt, Joke W. Baars
Publikováno v:
British journal of haematology, 105(1), 127-130. Wiley-Blackwell
British Journal of Haematology, 105, pp. 127-130
British Journal of Haematology, 127-130
STARTPAGE=127;ENDPAGE=130;ISSN=0007-1048;TITLE=British Journal of Haematology
British Journal of Haematology, 105, 127-130. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 105(1), 127-130. Wiley
British Journal of Haematology, 105, pp. 127-130
British Journal of Haematology, 127-130
STARTPAGE=127;ENDPAGE=130;ISSN=0007-1048;TITLE=British Journal of Haematology
British Journal of Haematology, 105, 127-130. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 105(1), 127-130. Wiley
Contains fulltext : 188587.pdf (Publisher’s version ) (Closed access) We examined the feasibility of achieving a rapid response in patients with previously untreated multiple myeloma by administering vincristine 0.4 mg and doxorubicin 9 mg/m2 as a
Publikováno v:
Histopathology. 30:152-159
To elucidate the role of cell turnover in primary gastric B-cell non-Hodgkin's lymphomas we studied tissue samples of 72 patients-26 small cell (25 MALT lymphomas) and 46 large cell (31 MALT lymphomas). Proliferation indices and apoptotic indices wer
Autor:
A. W. Dekker, G Ossenkoppele, Peter C. Huijgens, J van der Lelie, Leo F. Verdonck, Roelof Willemze, M. B. Van't Veer, Pieter Sonneveld, H. C. Schouten, Bob Löwenberg, W. L. J. Van Putten, W. Sizoo, H. L. Haak
Publikováno v:
Journal of Clinical Oncology. 15:476-482
PURPOSE To investigate the value of intensive consolidation chemotherapy not followed by maintenance therapy in adult acute lymphoblastic leukemia (ALL). MATERIALS AND METHODS A multicenter phase II trial was conducted in 130 adult patients with ALL